News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, February 4, 2019

Congressionally Directed Medical Research Programs (CDMRP) webinar series on funding

opportunities in both research and career development.   Over the next four months, webinars covering

topics from innovative research applications to clinical research.  For additional information go to: 

https://cdmrp.army.mil/pubs/Webinars/webinar_series

 

 

NSF Announcement:  Important revisions have been made to the Resumption of Operations at

NSF page on the NSF website, including identification of new deadline dates for specific solicitations

and Dear Colleague Letters.  This updated information will be of interest to your membership and we

would appreciate your sharing with your colleagues as soon as possible. This page will continue to

be updated as new information becomes available.   For more complete information go to:

https://www.nsf.gov/bfa/dias/policy/postshutdown.jsp

Policy-related questions regarding the resumption of operations at NSF may be addressed to

policy@nsf.gov.

 

 

Presbyterian Health Foundation (PHF)for specific programs and deadlines go to:

https://research.ouhsc.edu/News/presbyterian-health-foundation-grants-2019-request-for-applications

 

 

COMAA DEADLINE – Deadline April 1, 2019.  For additional information please see the attachment.

COMAA

 

Oklahoma Center for the Advancement of Science and Technology (OCAST)

Deadline of March 1, 2019       

Health Research Program (HR)

            Health Research Postdoctoral Fellowship Program (HF)

            Oklahoma Applied Research Support Program (AR)

Faculty and Student Intern Partnership (IP)

https://www.ok.gov/ocast/FUNDING_OPPORTUNITIES/index.html

 

 

Save the Date: ORA Noon Conference

Introduction to Grant Writing

Wednesday, February 13, 2019

Bird Library Auditorium, LIB-299 from 12:00 pm - 1:00 pm

This talk is designed to present a brief overview of the grant writing process and considerations for

new investigators or those new to grant writing. We will also touch upon ways to present evidence

that an applicant has been responsive to the areas that NIH deems important to enhancing rigor

and reproducibility, the corresponding NIH recommendations for the format of the research plan,

and the three key questions that reviewers are asked to consider when reviewing grant applications.

 

 

Grants and Contracts Accounting – Cost Transfers Class – Thursday, April 18, 2019 at

2:00PM.  Please go to the OUHSC HR Training Site for more complete information and to sign up.

 

 

OK-INBRE Research Project Investigator (RPI) Program

Proposal deadline: February 22, 2019

Call for proposals:

https://okinbre.ouhsc.edu/Funding-Opportunities/Funding-Opportunities-for-OUHSC-and-OMRF

The Oklahoma IDeA Network of Biomedical Research Excellence (OK-INBRE) is requesting

applications for Research Project Investigator Awards (RPI).  The program seeks to support

proposals designed to generate preliminary data that enhances the competitiveness of the

OUHSC/OMRF investigators for future extramural funding.  The proposed project must align

with one of the biomedical research themes of the OK-INBRE program: Cancer, Developmental

Biology or Infectious Diseases.  The RPI project period is 2 ½ years in duration funded at

$100,000 in direct costs per year.  Selected projects will commence in May 2019.

 

 

ORAU-Directed Research and Development (ODRD) Program

The FY 2019 competition for collaborative awards of up to $75,000 to be shared between the

university and ORAU researchers is now open. We anticipate and expect that these seed funds

will position the collaborative teams to be more competitive for new, external funding opportunities.

The deadline for joint ORAU/university proposals is March 25, 2019 and potential university

partners are encouraged to submit concepts for discussion with ORAU partners as soon as possible. 

https://www.orau.org/university-partnerships/member-grant-programs/odrd.html

 

 

NIH NOTICES

 

Additional Information Regarding RFA-OD-18-001 "Tobacco Regulatory Science Small Grant

Program for New Investigators (R03 Clinical Trial Optional)" and RFA-OD-18-003 "Tobacco

Regulatory Science (R21 Clinical Trial Optional)" (NOT-OD-19-047)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-047.html

 

Request for Information (RFI): Soliciting Additional Input to the NIH 2018 Tribal Consultation on

the Opioid Crisis in Indian Country (NOT-OD-19-059)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-059.html

 

Notice of Clarification of Eligibility for PAR-19-114 "Non-human Primates Facilities to Support

HIV/AIDS-related Research (C06) (Clinical Trial Not Allowed)" (NOT-OD-19-061)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-061.html

 

Notice of Intent to Publish the Reissuance of RFA-OD-18-002 "Tobacco Regulatory Science

(R01 Clinical Trial Optional)" (NOT-OD-19-062)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-062.html

 

Notice of Participation of the Office of Research on Womens Health (ORWH) in RFA-DA-19-029,

HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) (Collaborative R34

Clinical Trial Not Allowed) and RFA-DA-19-036, HEAL Initiative: HEA (NOT-OD-19-063)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-063.html

 

The National Institutes of Health (NIH) Sexual & Gender Minority Research Office (SGMRO)

Announces Pacific Regional Workshop on Sexual and Gender Minority (SGM)-Related Research

(NOT-OD-19-064)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-064.html

 

Notice of OBSSR Participation in RFA-DA-19-034, "HEAL Initiative: Coordinating Center to

Support NIDA Preventing Opioid Use Disorder in Older Adolescents and Young Adults

(ages 16-30) Initiative (U24 Clinical Trial Not Allowed)" (NOT-OD-19-065)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-065.html

 

Notice of OBSSR Participation in RFA-DA-19-035, "HEAL Initiative: Preventing Opioid Use

Disorder in Older Adolescents and Young Adults (ages 16-30) (UG3/UH3 Clinical Trial Required)"

(NOT-OD-19-066)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-066.html

 

Notice of NIAAA's participation in PAR-19-133, Academic Research Enhancement Award for

Undergraduate-Focused Institutions (R15-Clinical Trial Not Allowed) (NOT-AA-19-001)
https://grants.nih.gov/grants/guide/notice-files/NOT-AA-19-001.html

 

Notice of NIAAA's participation in PAR-19-134, Research Enhancement Award Program (REAP)

for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)

(NOT-AA-19-002)
https://grants.nih.gov/grants/guide/notice-files/NOT-AA-19-002.html

 

Notice of NIAAA's participation in PAR-19-135, Research Enhancement Award Program (REAP)

for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)

(NOT-AA-19-003)
https://grants.nih.gov/grants/guide/notice-files/NOT-AA-19-003.html

 

Notice of NIAAA's participation in NOT-OD-19-040 "Notice of Interest in Long-term Maintenance

of Behavior Change Research" (NOT-AA-19-004)
https://grants.nih.gov/grants/guide/notice-files/NOT-AA-19-004.html

 

Notice of Termination of PAR-19-164 "Summer Research Education Experience Program

(R25 Clinical Trial Not Allowed)" (NOT-AA-19-005)
https://grants.nih.gov/grants/guide/notice-files/NOT-AA-19-005.html

 

Notice of NIA's Withdrawal from Participation in RFA-DK-18-030, "HEAL Initiative: Integrated

Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription

Effort (HOPE) Consortium - Clinical Centers" (NOT-AG-19-001)
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-19-001.html

 

Notice of NIA's Withdrawal from Participation in RFA-DK-18-031, "HEAL Initiative: Integrated

Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid Prescription

Effort (HOPE) Consortium - Scientific and Data Research Center" (NOT-AG-19-002)
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-19-002.html

 

Notice of Change to Application Types for PAR-18-696, "Clinical Coordinating Center for NCCIH

Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical

Trial Required)" (NOT-AT-19-016)
https://grants.nih.gov/grants/guide/notice-files/NOT-AT-19-016.html

 

Notice of Pre-Application Webinar for the NIH Consortium for Advancing Research on Botanical

and Other Natural Products (CARBON) Program: RFA-AT-19-002, RFA-AT-19-003 and

RFA-OD-19-001 (NOT-AT-19-020)
https://grants.nih.gov/grants/guide/notice-files/NOT-AT-19-020.html

 

Notice of NIDCD Participation in PA-19-165 "Administrative Supplement for Research on Sex/

Gender Influences (Admin Supp Clinical Trial Optional)" (NOT-DC-19-005)
https://grants.nih.gov/grants/guide/notice-files/NOT-DC-19-005.html

 

Notice of Clarification: Funds Available for RFA-DE-19-008 Enabling Technologies to Accelerate

Development of Oral Biodevices (R21 Clinical Trial Not Allowed) (NOT-DE-18-028)
https://grants.nih.gov/grants/guide/notice-files/NOT-DE-18-028.html

 

Notice of Clarification: Funds Available for RFA-DE-19-009 Enabling Technologies to Accelerate

Development of Oral Biodevices (R01 Clinical Trial Not Allowed) (NOT-DE-18-029)
https://grants.nih.gov/grants/guide/notice-files/NOT-DE-18-029.html

 

Notice of Modifications to Instructions for Letters of Support in PAR-19-102 "Graduate Research

Training Initiative for Student Enhancement (RISE) (T32)" (NOT-GM-19-017)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-19-017.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Medical Rehabilitation

Research Resource (P2C Clinical Trial Optional) (NOT-HD-18-026)
https://grants.nih.gov/grants/guide/notice-files/NOT-HD-18-026.html

 

Notice of Change Application Due Date(s) for RFA-HD-19-024 "Women’s HIV Epidemiology

Cohort Studies (R01 - Clinical Trial Not Allowed)" (NOT-HD-19-002)
https://grants.nih.gov/grants/guide/notice-files/NOT-HD-19-002.html

 

Notice of Change: Emphasizing Opportunity for Developing Comprehensive Human Genome

Sequencing Methodologies in Response to NHGRI Novel Nucleic Acid Sequencing Technology

Development FOAs (NOT-HG-19-011)
https://grants.nih.gov/grants/guide/notice-files/NOT-HG-19-011.html

 

Notice of NHLBI Participation in PA-19-165 "Administrative Supplement for Research on Sex/

Gender Influences (Admin Supp Clinical Trial Optional)" (NOT-HL-19-675)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-19-675.html

 

Notice of Data Sharing Policy for the BRAIN Initiative (NOT-MH-19-010)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-010.html

 

 

Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.

 

NIH DEADLINES

 

Mechanistic studies on chronic alcohol use and sleep homeostasis (R01 Clinical Trial Optional)

(RFA-AA-19-006) – Deadline April 17, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-19-006.html

 

HIV/AIDS Clinical Trials Networks Laboratory Centers (UM1 Clinical Trial Required) (RFA-AI-19-001)

Deadline August 1, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-001.html

 

HIV/AIDS Clinical Trials Networks Statistical and Data Management Centers (SDMC) (UM1 Clinical

Trial Required) (RFA-AI-19-002) – Deadline August 1, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-002.html

 

HIV/AIDS Adult Therapeutics Clinical Trials Network Leadership and Operations Center

(UM1 Clinical Trial Required) (RFA-AI-19-003) – Deadline August 1, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-003.html

 

HIV/AIDS Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network Leadership and

Operations Center (UM1 Clinical Trial Required) (RFA-AI-19-004) – Deadline August 1, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-004.html

 

HIV Prevention Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial

Required) (RFA-AI-19-005) – Deadline August 1, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-005.html

 

HIV Vaccines Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial

Required) (RFA-AI-19-006) – Deadline August 1, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-006.html

 

Natural Products NMR Open Data Exchange (NP-NODE) (U24 Clinical Trial Not Allowed)

(RFA-AT-19-002) – Deadline April 1, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AT-19-002.html

 

Center for Natural Product Technology, Methodology, and Productivity Optimization (NP-TEMPO)

(U41 Clinical Trial Not Allowed) (RFA-AT-19-003) - Deadline April 29, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-AT-19-003.html

 

Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)

(RFA-CA-19-032) – Deadline August 1, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-032.html

 

Establishing a Cohort to Clarify Risk and Protective Factors for Neurocognitive Complications of

Pediatric Type 1 Diabetes (T1D) - Planning Cooperative Agreements (U34 Clinical Trial Not Allowed)

(RFA-DK-18-007) – Deadline April 11, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-007.html

 

Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of

Importance in Obesity Research (U01 Clinical Trial Not Allowed) (RFA-DK-19-001)

Deadline April 17, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-001.html

 

NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) (RFA-HL-20-011)

Deadline March 14, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-011.html

 

NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) (RFA-HL-20-012)

Deadline March 14, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-012.html

 

Limited Competition for a Connectome Coordination Facility (R24 Clinical Trial Not Allowed)

(RFA-MH-20-210) – Deadline June 24, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-210.html

 

Botanical Dietary Supplements Research Centers (U19 Clinical Trial Optional) (RFA-OD-19-001)

Deadline April 15, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-001.html

 

Implementation of shared decision making for HLBS diseases and conditions (R01 Clinical Trial

Optional) (PA-19-166) – Deadline June 5, 2019
https://grants.nih.gov/grants/guide/pa-files/PA-19-166.html

 

Development and Validation of Advanced Mammalian Models for Alzheimers Disease-Related

Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed) (PAR-19-167) – Deadline March 14, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-167.html

 

Biology of Bladder Cancer (R01 Clinical Trial Optional) (PAR-19-168) – Deadline June 5, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-168.html

 

Biology of Bladder Cancer (R21 Clinical Trial Optional) (PAR-19-169) – Deadline June 16, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-19-169.html

 

Progression Markers for Cognitive Impairment in Parkinson's Disease Dementia (R01 Clinical Trial

Not Allowed) (PAR-19-170) – Deadline March 8, 2019

https://grants.nih.gov/grants/guide/pa-files/PAR-19-170.html

 

OTHER FEDERAL DEADLINES

 

Defense Medical Research and Development Program (DMRDP) – Breast Cancer Research Program

(BCRP) – Breakthrough Award Levels 1 and 2 – Required Letter of Intent due March 14, 2019 and

Application Deadline is March 28, 2019

https://cdmrp.army.mil/funding/bcrp

 

Defense Medical Research and Development Program (DMRDP) – Breast Cancer Research Program

(BCRP) – Breakthrough Award Level 3 – Required Letter of Intent due March 12, 2019 and Application

Deadline is June 13, 2019

https://cdmrp.army.mil/funding/bcrp

 

Defense Medical Research and Development Program (DMRDP) – Breast Cancer Research Program

(BCRP) – Breakthrough Award Level 4– Required Letter of Intent due March 12, 2019 and Application

Deadline is June 13, 2019

https://cdmrp.army.mil/funding/bcrp

 

Defense Medical Research and Development Program (DMRDP) – Breast Cancer Research Program

(BCRP) – Era of Hope Scholar Award – Required Letter of Intent due March 14, 2019 and Application

Deadline is March 28, 2019

https://cdmrp.army.mil/funding/bcrp

 

Defense Medical Research and Development Program (DMRDP) – Breast Cancer Research Program

(BCRP) – Innovator Award – Required Letter of Intent due March 12, 2019 and Application Deadline is

June 13, 2019

https://cdmrp.army.mil/funding/bcrp

 

Defense Medical Research and Development Program (DMRDP) – Breast Cancer Research Program

(BCRP) – Distinguished Investigator Award – Required Letter of Intent due March 12, 2019 and Application

Deadline is June 13, 2019

https://cdmrp.army.mil/funding/bcrp

 

Defense Medical Research and Development Program (DMRDP) – Breast Cancer Research Program

(BCRP) – Breakthrough Fellowship Award – Required Letter of Intent due March 14, 2019 and Application

Deadline is March 28, 2019

https://cdmrp.army.mil/funding/bcrp

 

 

OTHER DEADLINES

Pat Tillman Foundation Scholarship- Deadline February 28, 2019

http://pattillmanfoundation.org

 

Robert Wood Johnson Foundation (RWJF) – Evidence for Action: Investigator-Initiated Research to

Build a Culture of Health – Deadline OPEN

https://www.rwjf.org/en/library/funding-opportunities/2015/evidence-for-action-investigator-initiated-research-to-build-a-culture-of-health.html?rid=0034400001rm6GKAAY&et_cid=1611010

 

 

New Clinical Study Opportunities

***************************************************************

Please note this is NOT a solicitation for study subjects

***************************************************************

Several Pharmaceutical companies are looking for Principal Investigators to participate in the following clinical studies:

  • IBS Study
  • Multiple Late Stage Oncology Studies
  • Pustular Psoriasis and Palmoplantar Pustulosis -MYA11966/MYA11999
  • A 6-Week, Acutely Psychotic Adult Subjects with Schizophrenia
  • A 56-Week Open-label Extension Study to Assess the Safety and Tolerability of XXXX in Adult

Subjects with Schizophrenia

Please contact Scott Davis at scott-davis@ouhsc.edu if you would like to receive more information on any of these

studies. The resulting confidentiality and/or clinical study agreement will need to be routed to the Office of Research

Administration.

 

Print

x